Revvity (RVTY) Stock Forecast, Price Target & Predictions
RVTY Stock Forecast
Revvity stock forecast is as follows: an average price target of $126.88 (represents a 9.33% upside from RVTY’s last price of $116.05) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
RVTY Price Target
The average price target for Revvity (RVTY) is $126.88 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $140.00 to $110.00. This represents a potential 9.33% upside from RVTY's last price of $116.05.
RVTY Analyst Ratings
According to 9 Wall Street analysts, Revvity's rating consensus is 'Buy'. The analyst rating breakdown for RVTY stock is 0 'Strong Buy' (0.00%), 5 'Buy' (55.56%), 4 'Hold' (44.44%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Revvity Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 04, 2024 | Paul Knight | KeyBanc | $132.00 | $124.82 | 5.75% | 13.74% |
| Oct 15, 2024 | Luke Sergott | Barclays | $140.00 | $122.91 | 13.90% | 20.64% |
| Jul 30, 2024 | Derik de Bruin | Bank of America Securities | $127.00 | $125.59 | 1.12% | 9.44% |
| Jul 29, 2024 | Tycho Peterson | Jefferies | $125.00 | $125.29 | -0.23% | 7.71% |
| Jul 29, 2024 | Daniel Arias | Stifel Nicolaus | $110.00 | $120.16 | -8.46% | -5.21% |
| Jul 29, 2024 | Vijay Kumar | Evercore ISI | $126.00 | $120.16 | 4.86% | 8.57% |
| Jul 29, 2024 | Patrick Donnelly | Citigroup | $135.00 | $120.16 | 12.35% | 16.33% |
| Apr 29, 2024 | Dan Leonard | UBS | $120.00 | $105.02 | 14.26% | 3.40% |
The latest Revvity stock forecast, released on Nov 04, 2024 by Paul Knight from KeyBanc, set a price target of $132.00, which represents a 5.75% increase from the stock price at the time of the forecast ($124.82), and a 13.74% increase from RVTY last price ($116.05).
Revvity Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 2 | 2 | 8 |
| Avg Price Target | $136.00 | $136.00 | $126.88 |
| Last Closing Price | $116.05 | $116.05 | $116.05 |
| Upside/Downside | 17.19% | 17.19% | 9.33% |
In the current month, the average price target of Revvity stock is $136.00, according to 2 Wall Street analysts offering twelve months forecast. The average price target represents a 17.19% increase as opposed to Revvity's last price of $116.05. This month's average price target is down 0.00% compared to last quarter, and up 7.19% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 04, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Oct 15, 2024 | Barclays | Equal-Weight | Overweight | Upgrade |
| Aug 27, 2024 | Wells Fargo | - | Equal-Weight | Initialise |
| Jul 30, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jul 30, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Jul 30, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
| Jul 29, 2024 | Jefferies | Hold | Hold | Hold |
| Jul 29, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 29, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Apr 30, 2024 | Cowen & Co. | Buy | Buy | Hold |
Revvity's last stock rating was published by KeyBanc on Nov 04, 2024. The company gave RVTY a "Overweight" rating, the same as its previous rate.
Revvity Financial Forecast
Revvity Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $674.87M | $741.21M | $711.80M | $1.23B | $1.26B | $1.36B | $1.17B | $1.23B | $1.31B | $1.35B | $964.02M | $811.72M | $652.40M | $805.50M | $706.92M |
| Avg Forecast | $826.77M | $762.19M | $771.71M | $716.15M | $773.01M | $721.66M | $728.86M | $684.32M | $731.12M | $679.66M | $690.33M | $647.25M | $677.13M | $695.40M | $708.38M | $678.90M | $1.03B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
| High Forecast | $837.87M | $772.43M | $782.08M | $725.77M | $783.39M | $731.35M | $738.65M | $691.93M | $748.94M | $679.73M | $690.33M | $647.45M | $682.85M | $706.09M | $717.90M | $688.02M | $1.04B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
| Low Forecast | $817.97M | $754.08M | $763.50M | $708.53M | $764.78M | $713.98M | $721.10M | $678.02M | $721.46M | $679.58M | $690.32M | $647.04M | $669.72M | $685.27M | $700.84M | $671.68M | $1.02B | $1.02B | $1.20B | $1.19B | $1.27B | $1.04B | $1.12B | $1.21B | $1.23B | $840.15M | $722.01M | $649.26M | $801.08M | $721.38M |
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.72% | 0.70% | 1.02% | 1.06% | 1.07% | 1.12% | 1.09% | 1.08% | 1.11% | 1.15% | 1.12% | 1.00% | 1.01% | 0.98% |
Revvity's average Quarter revenue forecast for Jun 23 based on 8 analysts is $708.38M, with a low forecast of $700.84M, and a high forecast of $717.90M. RVTY's average Quarter revenue forecast represents a 4.97% increase compared to the company's last Quarter revenue of $674.87M (Mar 23).
Revvity EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $158.42M | $266.62M | $220.69M | $380.02M | $391.55M | $465.46M | $313.89M | $414.87M | $551.24M | $546.42M | $312.35M | $236.86M | $114.97M | $170.25M | $147.27M |
| Avg Forecast | $257.67M | $237.54M | $240.51M | $223.19M | $240.91M | $224.91M | $227.15M | $213.27M | $227.86M | $211.82M | $215.15M | $201.72M | $211.03M | $216.73M | $220.77M | $211.59M | $320.65M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
| High Forecast | $261.13M | $240.73M | $243.74M | $226.19M | $244.15M | $227.93M | $230.21M | $215.65M | $233.41M | $211.84M | $215.15M | $201.78M | $212.81M | $220.06M | $223.74M | $214.43M | $324.95M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
| Low Forecast | $254.93M | $235.01M | $237.95M | $220.82M | $238.35M | $222.52M | $224.74M | $211.31M | $224.85M | $211.80M | $215.14M | $201.65M | $208.72M | $213.57M | $218.42M | $209.33M | $317.23M | $305.05M | $359.56M | $355.16M | $380.39M | $310.97M | $335.36M | $361.69M | $365.93M | $250.95M | $215.67M | $193.94M | $239.28M | $215.48M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.75% | 0.83% | 0.72% | 1.06% | 1.10% | 1.22% | 1.01% | 1.24% | 1.52% | 1.49% | 1.24% | 1.10% | 0.59% | 0.71% | 0.68% |
8 analysts predict RVTY's average Quarter EBITDA for Jun 23 to be $220.77M, with a high of $223.74M and a low of $218.42M. This is 39.36% upper than Revvity's previous annual EBITDA (Mar 23) of $158.42M.
Revvity Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $24.84M | $107.50M | $85.35M | $179.21M | $176.96M | $179.18M | $127.74M | $245.93M | $379.31M | $380.36M | $176.70M | $137.16M | $33.66M | $64.50M | $58.56M |
| Avg Forecast | $198.61M | $173.14M | $176.56M | $155.69M | $181.37M | $157.47M | $158.77M | $136.44M | $168.58M | $138.57M | $138.02M | $115.96M | $143.29M | $146.85M | $146.25M | $122.86M | $201.61M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
| High Forecast | $202.08M | $176.16M | $179.64M | $158.41M | $184.54M | $160.22M | $161.55M | $147.21M | $173.51M | $138.59M | $138.03M | $116.36M | $147.02M | $154.26M | $146.47M | $125.01M | $205.13M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
| Low Forecast | $195.86M | $170.75M | $174.12M | $153.53M | $178.86M | $155.29M | $156.58M | $130.46M | $163.66M | $138.55M | $138.01M | $115.55M | $142.04M | $141.92M | $146.04M | $121.16M | $198.82M | $177.82M | $248.69M | $261.16M | $277.54M | $214.86M | $300.90M | $381.43M | $371.86M | $185.64M | $104.51M | $68.78M | $163.69M | $124.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | 0.53% | 0.48% | 0.72% | 0.68% | 0.65% | 0.59% | 0.82% | 0.99% | 1.02% | 0.95% | 1.31% | 0.49% | 0.39% | 0.47% |
Revvity's average Quarter net income forecast for Jun 23 is $146.25M, with a range of $146.04M to $146.47M. RVTY's average Quarter net income forecast represents a 488.67% increase compared to the company's last Quarter net income of $24.84M (Mar 23).
Revvity SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $248.56M | $244.32M | $239.97M | $330.02M | $334.39M | $355.25M | $339.05M | $281.82M | $251.41M | $263.05M | $225.25M | $221.03M | $208.57M | $210.74M | $204.17M |
| Avg Forecast | $239.61M | $220.89M | $223.65M | $207.55M | $224.03M | $209.14M | $211.23M | $198.32M | $211.88M | $196.97M | $200.06M | $187.58M | $196.24M | $201.53M | $205.30M | $196.75M | $298.17M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
| High Forecast | $242.82M | $223.86M | $226.65M | $210.34M | $227.04M | $211.95M | $214.07M | $200.53M | $217.05M | $196.99M | $200.06M | $187.64M | $197.90M | $204.63M | $208.05M | $199.40M | $302.17M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
| Low Forecast | $237.06M | $218.54M | $221.27M | $205.34M | $221.64M | $206.92M | $208.98M | $196.50M | $209.09M | $196.95M | $200.06M | $187.52M | $194.09M | $198.60M | $203.11M | $194.66M | $295.00M | $268.86M | $316.90M | $313.02M | $335.26M | $274.08M | $295.57M | $318.77M | $322.52M | $221.18M | $190.08M | $170.93M | $210.89M | $189.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.26% | 0.82% | 0.89% | 1.04% | 1.07% | 1.06% | 1.24% | 0.95% | 0.79% | 0.82% | 1.02% | 1.16% | 1.22% | 1.00% | 1.08% |
Revvity's average Quarter SG&A projection for Jun 23 is $205.30M, based on 8 Wall Street analysts, with a range of $203.11M to $208.05M. The forecast indicates a -17.40% fall compared to RVTY last annual SG&A of $248.56M (Mar 23).
Revvity EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 9 | 4 | 3 | 3 | 6 | 12 | 8 | 8 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.20 | $0.85 | $0.68 | $1.42 | $1.40 | $1.42 | $1.12 | $2.20 | $3.39 | $3.40 | $1.58 | $1.23 | $0.30 | $0.58 | $0.53 |
| Avg Forecast | $1.61 | $1.41 | $1.44 | $1.27 | $1.47 | $1.28 | $1.29 | $1.11 | $1.37 | $1.13 | $1.12 | $0.94 | $1.16 | $1.19 | $1.19 | $1.00 | $1.64 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
| High Forecast | $1.64 | $1.43 | $1.46 | $1.29 | $1.50 | $1.30 | $1.31 | $1.20 | $1.41 | $1.13 | $1.12 | $0.95 | $1.20 | $1.25 | $1.19 | $1.02 | $1.67 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
| Low Forecast | $1.59 | $1.39 | $1.42 | $1.25 | $1.45 | $1.26 | $1.27 | $1.06 | $1.33 | $1.13 | $1.12 | $0.94 | $1.15 | $1.15 | $1.19 | $0.98 | $1.62 | $1.44 | $2.01 | $2.12 | $2.25 | $1.74 | $2.44 | $3.09 | $3.01 | $1.50 | $0.85 | $0.56 | $1.33 | $1.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | 0.52% | 0.47% | 0.71% | 0.66% | 0.63% | 0.64% | 0.90% | 1.10% | 1.13% | 1.05% | 1.45% | 0.54% | 0.44% | 0.53% |
According to 8 Wall Street analysts, Revvity's projected average Quarter EPS for Jun 23 is $1.19, with a low estimate of $1.19 and a high estimate of $1.19. This represents a 494.40% increase compared to RVTY previous annual EPS of $0.20 (Mar 23).
Revvity Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | $2.18 | $14.00 | 542.20% | Buy |
| ICLR | ICON Public Limited Company | $200.02 | $309.60 | 54.78% | Buy |
| CRL | Charles River Laboratories | $196.90 | $303.60 | 54.19% | Buy |
| IQV | IQVIA | $202.94 | $266.65 | 31.39% | Buy |
| QGEN | Qiagen | $42.09 | $51.89 | 23.28% | Buy |
| NEOG | Neogen | $14.64 | $17.50 | 19.54% | Buy |
| MEDP | Medpace | $334.84 | $399.20 | 19.22% | Hold |
| LH | Laboratory Corporation of America | $238.18 | $281.25 | 18.08% | Buy |
| A | Agilent | $130.22 | $152.64 | 17.22% | Buy |
| IDXX | IDEXX Laboratories | $423.65 | $479.75 | 13.24% | Buy |
| RVTY | Revvity | $116.05 | $126.88 | 9.33% | Buy |
| TWST | Twist Bioscience | $38.96 | $42.40 | 8.83% | Buy |
| MTD | Mettler-Toledo | $1.24K | $1.34K | 8.61% | Hold |
| WAT | Waters | $376.72 | $356.80 | -5.29% | Buy |
| OLK | Olink AB (publ) | $26.08 | $21.50 | -17.56% | Hold |